{
  "system_prompt": "You are a buy-side equity PM constructing a long-only portfolio from scored candidates.\nRules:\n- Select exactly 20 stocks from the scored candidates provided.\n- Assign weights between 2% and 10% per stock (0.02 to 0.10).\n- Weights must sum to exactly 100% (1.0).\n- Diversify across sectors and industries (respect sector_cap and industry_cap constraints).\n- Prioritize stocks with higher composite scores, but ensure diversification.\n- Consider sector/industry balance and avoid over-concentration.\n- Output must be strict JSON.",
  "user_prompt": "Portfolio Construction Task:\n\n      Investment Horizon: Today to 2026-05-15 (148 days remaining)\n\n      Constraints:\n      - Select EXACTLY 20 stocks\n      - Weight per stock: 2% to 10% (0.02 to 0.10)\n      - Total weight must sum to EXACTLY 100% (1.0)\n      - Sector cap: 35% (no single sector > 35%)\n      - Industry cap: 20% (no single industry > 20%)\n      - Long-only portfolio (no short positions)\n\n      Scored Candidates (sorted by composite score, showing top 40):\n        NEM: score=0.773, sector=Materials, sentiment=bullish, price=$99.45\n  News: Newmont Corporation (NEM) recently reached an all-time high of $102.13, driven by strong gold prices and significant hedge fund interest, marking a 150% total shareholder return over the past year. Despite this momentum, the company is facing challenges with declining gold production, which is expected to impact Q4 performance due to asset sales and lower grades. Overall, while NEM has shown resilience and growth potential, investors should remain cautious about the sustainability of its recent gains amid fluctuating production levels.\nADBE: score=0.660, sector=Information Technology, sentiment=bullish, price=$354.66, theme=Digital Transformation Across Industries\n  News: Adobe Inc. reported a strong Q4 2025, surpassing earnings expectations, driven by increased demand for its AI-powered tools and significant user engagement across its applications. Despite facing heightened competition in the AI space, analysts remain optimistic, with Bernstein maintaining an 'Outperform' rating and a price target of $506. The integration of generative AI features has notably enhanced Adobe's product offerings, contributing to robust enterprise adoption and user growth. Overall, Adobe's performance reflects a positive trend in leveraging AI technology, positioning it favorably in the market.\nMRK: score=0.642, sector=Health Care, sentiment=bullish, price=$99.18\n  News: Merck & Co., Inc. (MRK) has recently received positive attention from analysts, with BofA raising its price target from $105 to $120 and highlighting the attractiveness of its pipeline. The company also reported promising Phase 3 results for KEYTRUDA in combination with Padcev for muscle-invasive bladder cancer, which could enhance its market position. Additionally, MRK is considered one of the most undervalued stocks in the pharmaceutical sector, with mixed analyst views as it progresses through regulatory reviews in Europe. Overall, these developments suggest a potentially favorable outlook for MRK in the coming months.\nGOOGL: score=0.619, sector=Communication Services, sentiment=bullish, price=$296.72, theme=AI Infrastructure Buildout\n  News: Alphabet Inc. (GOOGL) is positioned as a strong contender in the AI sector, with predictions suggesting it could join the $5 trillion market cap club by 2026 alongside Nvidia. However, the stock recently experienced a decline, closing down approximately 3.21% in the latest trading session. The ongoing AI arms race is impacting Big Tech balance sheets, with significant capital expenditures expected in the coming years. Additionally, regulatory scrutiny regarding immigration policies may affect operational costs for Alphabet and other major firms.\nV: score=0.602, sector=Information Technology, sentiment=bullish, price=$344.41\n  News: Visa (V) has recently gained approximately 7% in share price over the past month, reflecting strong investor confidence and a solid year-to-date performance. The company is advancing its presence in the cryptocurrency space by introducing USDC settlement for U.S. partners, which enables 24/7 blockchain-based transactions. This strategic move, along with a collaboration with Akamai Technologies to enhance security in agentic commerce, positions Visa as a key player in the evolving fintech landscape. Overall, Visa's long-term momentum remains robust, with a three-year total shareholder return exceeding 70%.\nMA: score=0.566, sector=Information Technology, sentiment=bullish, price=$565.47\n  News: Mastercard (NYSE: MA) has recently made significant strides in expanding its digital payment capabilities, including a 45% increase in its acceptance network across Africa, which is expected to accelerate the continent's digital economy. The company also announced a strategic partnership with LoanPro to launch 'Loan on Card' in 2026, enhancing lending options for consumers and small businesses. Additionally, Mastercard's board approved a $14 billion share repurchase program and raised its quarterly dividend by 14%, reflecting strong cash generation and a commitment to shareholder returns. Evercore ISI has raised its price target for Mastercard to $610, indicating positive market sentiment towards the stock.\nSHOP: score=0.520, sector=Consumer Discretionary, sentiment=bullish, price=$161.73, theme=E-Commerce and Consumer Behavior Evolution\n  News: Shopify's stock has seen a significant surge, with shares up over 50% year-to-date and recently reaching $164.19, driven by strong quarterly earnings and positive market sentiment. Analysts maintain a fair value estimate around $175.43 per share, reflecting confidence in Shopify's growth potential despite a high valuation. The company is also benefiting from new partnerships, such as with Square, which enhance its multi-channel inventory management capabilities. Overall, the momentum suggests a robust outlook for Shopify as it continues to capitalize on its commerce platform's strengths.\nMETA: score=0.510, sector=Communication Services, sentiment=bullish, price=$649.5\n  News: Meta Platforms is gaining attention from Wall Street analysts, with expectations of a 47% upside in its stock due to successful investments in artificial intelligence, despite recent market concerns. The company's post-earnings sell-off is viewed as a potential buying opportunity. Additionally, Meta, along with other tech giants, has received authorization from the Federal Energy Regulatory Commission to engage in wholesale power trading, indicating a strategic move into energy markets. These developments highlight Meta's ongoing innovation and diversification efforts, which could positively impact its long-term growth prospects.\nJPM: score=0.507, sector=Financials, sentiment=bullish, price=$314.98, theme=Interest Rate Sensitivity and Financial Sector Dynamics\n  News: JPMorgan Chase (JPM) continues to maintain an 'Outperform' recommendation from analysts at Keefe, Bruyette & Woods, reflecting confidence in the bank's performance. As big bank stocks are poised to close 2025 at record highs, JPM is expected to benefit from broader growth goals set for 2026. The financial sector is experiencing mixed performance, but overall sentiment remains positive as analysts refine their outlooks for major banks, including JPMorgan. Investors should monitor these trends as they could influence future stock performance.\nREGN: score=0.500, sector=Healthcare, sentiment=bullish, price=$749.79, theme=Healthcare Innovation and Value Investing\n  News: Regeneron Pharmaceuticals (REGN) recently reported promising Phase 1/2 data for its multiple myeloma therapy Lynozyfic\u2122 and announced a collaboration with Tessera Therapeutics to develop a gene therapy candidate for alpha-1 antitrypsin deficiency. Following these developments, REGN's stock rose by 5.4%, reflecting investor optimism about its expanding oncology and genetic medicine pipeline. Additionally, analysts suggest that despite recent setbacks, there are compelling reasons to consider REGN as a strong investment opportunity moving forward.\nAAPL: score=0.478, sector=Information Technology, sentiment=bullish, price=$271.84, theme=Geopolitical Tensions and Supply Chain Resilience\n  News: Apple has announced significant changes to its iOS platform in Japan to comply with the Mobile Software Competition Act, allowing developers more flexibility in app distribution and payment processing. Additionally, Morgan Stanley predicts that Apple will transition from an AI laggard to a leader by 2026, particularly with advancements in its Siri digital assistant. The company is also planning a major expansion of its iPhone lineup, potentially introducing seven models by 2027 as global sales accelerate. These developments come amid a broader tech sector selloff, with the Nasdaq Composite experiencing its worst day in nearly four weeks.\nAMGN: score=0.466, sector=Healthcare, sentiment=neutral, price=$326.01, theme=Healthcare Innovation and Value Investing\n  News: Amgen (AMGN) recently received FDA approval for UPLIZNA, expanding its market in autoimmune diseases, which has contributed to an 18.94% increase in its stock price over the past three months. HSBC has raised its price target for Amgen to $425, maintaining a Buy rating, while Morgan Stanley has slightly reduced its target to $304 but remains optimistic about the biopharma outlook. Additionally, Amgen's dividend yield is now above 3%, reflecting its strong position among blue-chip stocks. Overall, investor interest in Amgen is growing, driven by recent drug approvals and favorable market conditions.\nABT: score=0.446, sector=Health Care, sentiment=bullish, price=$126.71\n  News: Abbott Laboratories (ABT) has recently gained attention as its stock rose 2.4% to $128.47 amid a broader market dip, driven by its expansion of the Lingo biowearable to the Android platform, enhancing access to real-time glucose monitoring. The company is also benefiting from the growing blood glucose monitor market, projected to reach $25.4 billion by 2030. Additionally, Abbott's strategic moves in the healthcare sector, including its involvement in the Exact Sciences acquisition, are positively influencing market perceptions and valuations. Investors are closely monitoring these developments as they assess ABT's long-term growth potential and competitive positioning.\nVZ: score=0.443, sector=Communication Services, sentiment=bullish, price=$40.88, theme=Digital Transformation Across Industries\n  News: Verizon Communications Inc. has announced a strategic partnership with Array Digital Infrastructure to enhance its 5G network, leveraging Array's nationwide tower footprint for improved coverage. Despite a slight reduction in its fair value estimate to approximately $47.48 per share, analysts remain cautiously optimistic about Verizon's fundamentals amid leadership changes and restructuring efforts. The competitive landscape is intensifying as T-Mobile and AT&T ramp up their offerings, highlighting the need for Verizon to execute effectively on its growth initiatives.\nJNJ: score=0.441, sector=Health Care, sentiment=bullish, price=$210.33\n  News: Johnson & Johnson (NYSE: JNJ) has received FDA approval for RYBREVANT FASPRO\u2122, a new subcutaneous therapy for non-small cell lung cancer, which is expected to enhance its product portfolio and growth prospects. BofA has raised its price target for JNJ to $220, citing the company's premium valuation as justified by its growth and asset mix. Analysts are increasingly viewing JNJ as a strong investment option, with recent discussions highlighting its potential for sustained growth and margin improvement.\nSYK: score=0.440, sector=Health Care, sentiment=bullish, price=$352.58\n  News: Stryker Corporation (NYSE: SYK) has announced a 4.8% increase in its quarterly dividend to $0.88 per share, reflecting confidence in its financial performance. Despite a flat share performance this year, with a slight decline of 2.0% year-to-date, the stock has shown significant growth over the past three to five years. The company is also positioned to benefit from advancements in AI within the MedTech sector, as well as growth in the cranio maxillofacial fixation devices market. Citigroup has maintained a 'Buy' recommendation on the stock, indicating continued investor optimism amidst recent performance challenges.\nPFE: score=0.425, sector=Health Care, sentiment=neutral, price=$25.04\n  News: Morgan Stanley has maintained an Equal-Weight rating on Pfizer (PFE) while lowering its price target to $28, reflecting a neutral market outlook amid concerns over the company's soft 2026 revenue and EPS guidance due to declining COVID-19 demand and patent expirations. Despite being identified as one of the most undervalued pharmaceutical stocks, PFE faces structural challenges that have led to a Hold rating from analysts. Recent clinical trial results for its cancer treatment in collaboration with Astellas Pharma show promise, but overall investor sentiment remains cautious.\nNVDA: score=0.417, sector=Information Technology, sentiment=bullish, price=$170.94, theme=AI Infrastructure Buildout\n  News: NVIDIA Corporation (NASDAQ: NVDA) has seen increased investor confidence, with activist investor Dan Loeb's Third Point LLC raising its stake by 2% in Q3 2025, reflecting a strong belief in the company's AI potential. Amidst a broader tech sell-off, NVIDIA and Alphabet are both predicted to reach $5 trillion market caps by 2026, highlighting their dominance in the AI sector. Despite recent market volatility affecting tech stocks, NVIDIA remains a key player in the AI landscape, with its GPUs driving significant advancements. Overall, the outlook for NVIDIA appears robust as it continues to lead in AI technology.\nCSCO: score=0.416, sector=Information Technology, sentiment=bullish, price=$76.0\n  News: Cisco Systems (CSCO) is currently trading near a 52-week high, reflecting a significant 33.8% surge driven by increasing demand for AI technologies. However, analysts caution that high valuations and macroeconomic risks could limit further upside in 2026. In a competitive landscape, Fortinet's strong performance in cybersecurity poses a challenge to Cisco's broader growth narrative. Amidst a broader tech sector selloff, CSCO's stock remains a focal point for investors considering its recent performance and market conditions.\nEBAY: score=0.403, sector=Consumer Discretionary, sentiment=neutral, price=$82.71, theme=E-Commerce and Consumer Behavior Evolution\n  News: eBay's stock recently fell 3% following the European Union's announcement of new customs duties on low-value e-commerce packages, raising concerns about its competitive position. Despite this setback, analysts have shown a cautiously optimistic outlook, maintaining a fair value estimate of around $94 per share and projecting modest revenue growth. Additionally, the introduction of eBay Live is seen as a potential catalyst for future growth, while the company's performance has outpaced many peers in the e-commerce sector over the past year.\nMSFT: score=0.401, sector=Information Technology, sentiment=bullish, price=$476.12, theme=Digital Transformation Across Industries\n  News: Microsoft (MSFT) has experienced a 6% pullback over the past month, raising questions about its valuation amid strong long-term returns. This decline follows a robust year-to-date performance and suggests a cooling momentum in its stock price. Additionally, concerns are growing among investors regarding the pace of AI investments by major tech companies, including Microsoft, which could impact future growth expectations. As the AI arms race intensifies, with significant capital expenditures projected, MSFT's position in this competitive landscape remains critical for its future performance.\nKO: score=0.399, sector=Consumer Staples, sentiment=bullish, price=$70.67\n  News: Coca-Cola (NYSE:KO) is facing challenges in its attempt to sell Costa Coffee, with reports indicating that negotiations with private equity firm TDR Capital are faltering. This situation raises questions about the company's valuation and investor confidence. Additionally, Coca-Cola remains a notable inclusion among the 'Best Dogs of the Dow,' highlighting its potential as a stable investment despite current difficulties. The market is closely watching these developments as they could impact Coca-Cola's long-term growth strategy.\nMAS: score=0.374, sector=Materials, sentiment=bullish, price=$65.11, theme=Infrastructure Spending Surge\n  News: Masco (MAS) has recently undergone a leadership restructuring aimed at driving long-term growth, with a new Executive Committee set to take effect in January 2026. Despite a mixed performance, including a 6.86% return over the past month and a year-to-date decline of 9.35%, analysts remain optimistic about its future potential. The stock has experienced a 10% drop amid housing demand uncertainties, yet it has achieved a notable 37% gain over the past three years. Additionally, Wells Fargo has upgraded the stock, while Barclays has issued a downgrade, reflecting mixed sentiment in the market.\nMCD: score=0.372, sector=Consumer Discretionary, sentiment=neutral, price=$318.69\n  News: McDonald's (MCD) recently closed at $314.5, reflecting a decline of 1.33%, which is steeper than the broader market's performance. The company is facing challenges as it plans to close 200 restaurants amid changing consumer spending habits, although it remains a favored brand among certain consumers. Barclays has maintained a Buy rating on MCD, highlighting its strong value focus and digital capabilities, with a price target of $358. Overall, MCD is recognized as one of the best-performing stocks in the Dow for 2025, despite current market pressures.\nWFC: score=0.367, sector=Financials, sentiment=bullish, price=$92.59, theme=Interest Rate Sensitivity and Financial Sector Dynamics\n  News: Wells Fargo (WFC) has seen a positive shift in its investment narrative, with analysts raising its fair value estimate to $94.50, driven by stronger fee income and improved capital returns, despite a slight easing in revenue growth expectations. The bank is also focusing on branch renovations as a key growth strategy to enhance customer engagement and expand product offerings. Additionally, WFC has adopted a more constructive outlook on U.S. retailers for 2026, indicating a recovery in the sector's fundamentals. Overall, the banking sector is poised to close 2025 at record highs, reflecting broader growth goals for the upcoming year.\nHD: score=0.362, sector=Consumer Discretionary, sentiment=bullish, price=$356.75\n  News: Home Depot (HD) has experienced a recent share price pullback despite steady revenue and net income growth, indicating a potential disconnect in market perception. Analysts have adjusted their fair value estimates slightly downward, reflecting a more cautious outlook for near-term revenue growth. Additionally, Jim Cramer has expressed a preference for Home Depot over competitors like Builders FirstSource, suggesting confidence in its long-term prospects. However, broader economic headwinds, including weak housing and rising consumer debt, may pose challenges ahead.\nLIN: score=0.357, sector=Materials, sentiment=bullish, price=$422.34\n  News: Linde plc (NASDAQ:LIN) has recently faced stock price pressure, declining approximately 2.6% over the past week and 4.5% over the last month, despite strong earnings of $8.6 billion for Q3 2025 and a positive Outperform rating from CICC with a $510 price target. Analysts are divided on whether the recent pullback represents a buying opportunity or reflects deeper concerns about the company's valuation amidst market scrutiny. Additionally, Linde secured a $1.50 billion short-term revolving credit facility, highlighting its financial stability despite market volatility. Overall, Linde remains a key player in the industrial gas sector, with ongoing growth potential in AI and electronics.\nZTS: score=0.357, sector=Health Care, sentiment=bullish, price=$122.25\n  News: Zoetis Inc. (ZTS) recently completed a $1.75 billion offering of convertible senior notes, primarily to fund share repurchases and support its capital allocation strategy. The company also announced a 6% increase in its quarterly dividend, raising it to $0.53, amidst ongoing economic uncertainty that has led to a shift towards income-focused investments. Despite these positive developments, Zoetis shares have seen a year-to-date decline of approximately 25%, and HSBC has cut its price target for the stock from $180 to $140 while maintaining a Buy rating.\nLOW: score=0.345, sector=Consumer Discretionary, sentiment=bullish, price=$247.96\n  News: Lowe's Companies, Inc. (NYSE:LOW) has been highlighted as a strong performer in the home furnishing and improvement retail sector during the Q3 earnings season, attracting significant institutional interest with 79% of shares held by institutions. However, returns on capital for Lowe's have stalled, raising concerns about future growth potential. As the market approaches 2026, Lowe's is noted for its stability and tech adoption, positioning it favorably compared to peers like Home Depot, which may face challenges in Q4 due to difficult sales comparisons. Overall, while Lowe's shows promise, investors should monitor its capital returns and market dynamics closely.\nTMO: score=0.345, sector=Health Care, sentiment=bullish, price=$562.56\n  News: Thermo Fisher Scientific (TMO) is experiencing positive momentum following recent analyst upgrades, including a new price target of $670 from Morgan Stanley, reflecting confidence in its expansion in bioprocessing and cardiovascular testing. The company has also launched new formulations in its Gibco Bacto portfolio aimed at enhancing E. coli-based production efficiency, which could drive future growth. Additionally, TMO's involvement in the blood collection tubes market presents further opportunities, as demand is rising due to innovations and regulatory needs. Overall, TMO's strategic initiatives and favorable market conditions position it well for continued growth.\nBMY: score=0.344, sector=Healthcare, sentiment=bullish, price=$53.55, theme=Healthcare Innovation and Value Investing\n  News: Bristol-Myers Squibb (BMY) has recently garnered positive attention from analysts, with Guggenheim upgrading its rating to 'Buy' and setting a price target of $62, while BofA Securities also upgraded the stock, contributing to a 3.7% increase in share price. The company is involved in a significant collaboration with Harbour BioMed to develop next-generation multi-specific antibodies, which could yield up to $1.035 billion in potential milestones. Overall, BMY is being recognized as one of the most undervalued stocks in the pharmaceutical sector, attracting investor interest amid a rising healthcare market.\nBAC: score=0.338, sector=Financials, sentiment=bullish, price=$54.55, theme=Interest Rate Sensitivity and Financial Sector Dynamics\n  News: Bank of America (BAC) has maintained its 'Outperform' recommendation, reflecting confidence in its performance amid a broader trend of big banks closing the year at record highs and setting ambitious growth goals for 2026. The bank is also focusing on AI stocks for 2026, highlighting key players like Nvidia and Broadcom, despite recent volatility in the sector. Additionally, BAC's recent transparency notifications indicate a shift in its holdings, further emphasizing its active management strategy in the market.\nMDT: score=0.337, sector=Health Care, sentiment=bullish, price=$98.3\n  News: Medtronic (MDT) has received FDA clearance for its Hugo robotic-assisted surgery system, enhancing its capabilities in urologic procedures, while also launching the MiniMed 780G system for diabetes management. The company has demonstrated a solid performance with a 24% year-to-date share price increase and a consistent dividend growth record, recently declaring a cash dividend of $0.71 per share. Despite a recent dip in the healthcare sector, MDT's advancements in robotics and diabetes technology may positively influence its investment narrative moving forward.\nNFLX: score=0.335, sector=Communication Services, sentiment=bullish, price=$94.79\n  News: Netflix (NFLX) is gaining traction as Warner Bros. Discovery has rejected a $108 billion bid from Paramount, indicating a preference for a potential deal with Netflix. This development suggests that Netflix is positioning itself strategically within the media landscape, potentially enhancing its market share. Additionally, the streaming service is facing increased competition as Apple TV introduces features that Netflix has recently dropped, highlighting the ongoing challenges in the streaming sector. Overall, these dynamics could influence investor sentiment and decisions regarding NFLX's future performance.\nMS: score=0.318, sector=Financials, sentiment=bullish, price=$174.8, theme=Interest Rate Sensitivity and Financial Sector Dynamics\n  News: Morgan Stanley (MS) continues to receive positive attention, with Keefe, Bruyette & Woods maintaining an 'Outperform' recommendation for the stock. As big banks, including Morgan Stanley, are projected to close 2025 at record highs, the sector anticipates broader growth goals for 2026. Additionally, Morgan Stanley is actively involved in analyzing key central bank meetings, which could influence market dynamics moving forward. Overall, the outlook for MS remains optimistic amid a favorable banking environment.\nGILD: score=0.310, sector=Healthcare, sentiment=bullish, price=$121.36, theme=Healthcare Innovation and Value Investing\n  News: Gilead Sciences (GILD) has achieved a significant milestone with its bictegravir and lenacapavir regimen meeting non-inferiority to Biktarvy in the Phase 3 ARTISTRY-2 trial, bolstering its HIV treatment pipeline. Despite a recent cooling in stock performance, with a 4.6% decline over the past month, GILD remains up 32.1% year-to-date. The stock closed at $121.36, reflecting a 2.17% increase in the latest trading session, indicating resilience amid market fluctuations. Investors are weighing whether the current valuation still offers value following a substantial price surge this year.\nAIG: score=0.307, sector=Financials, sentiment=neutral, price=$86.14, theme=Interest Rate Sensitivity and Financial Sector Dynamics\n  News: American International Group (AIG) has made significant leadership changes, appointing Adam Clifford as CEO of International Commercial Insurance and Scott Leney as Regional President for Asia Pacific, which may enhance its global profitability strategy. Additionally, AIG's stock has seen a notable increase of over 10% following reports of an informal takeover approach from Chubb, indicating strong market interest and potential consolidation in the insurance sector. Analysts from Mizuho and TD Cowen have initiated coverage and maintained a hold recommendation, respectively, reflecting cautious optimism about AIG's future performance.\nLMT: score=0.285, sector=Industrials, sentiment=bullish, price=$474.79, theme=Geopolitical Tensions and Supply Chain Resilience\n  News: Lockheed Martin (LMT) has recently achieved significant milestones, including the completion of F-16 Block 70 production for Bulgaria and Slovakia, and advancements in AI-enabled unmanned systems and missile defense capabilities. However, the stock faced downward pressure following a downgrade from Morgan Stanley and potential executive orders from the Trump administration that may restrict dividends and stock buybacks for defense contractors. This combination of positive operational developments and negative market sentiment has led to the end of a 10-day winning streak for LMT shares.\nPEP: score=0.275, sector=Consumer Staples, sentiment=bullish, price=$150.08\n  News: PepsiCo (NASDAQ: PEP) received a price target increase from Barclays, raising it to $144, reflecting confidence in its 2026 outlook. The company is focusing on a robust innovation pipeline to drive growth amidst shifting consumer preferences. Additionally, PepsiCo has made executive team changes to enhance performance following pressure from activist investor Elliott Investment Management. Recent FTC allegations suggested that PepsiCo provided Walmart with preferential pricing, which could impact its market positioning.\nUNH: score=0.275, sector=Health Care, sentiment=bullish, price=$331.63\n  News: UnitedHealth Group (NYSE: UNH) has agreed to sell its South American business, Banmedica, to Patria Investments for $1 billion, marking a strategic exit from the region. Despite facing a challenging year with a 33% decline in stock value, analysts suggest that most negatives are priced in, indicating potential for recovery in 2026. Jim Cramer has recommended buying UNH, highlighting its prospects for renewed growth as health insurers regain pricing control. The stock recently closed at $334.2, reflecting a slight decline, but analysts maintain a Buy rating as the company positions itself for a turnaround.\n\n      Instructions:\n      1. Select the best 20 stocks considering:\n         - Composite score (higher is better)\n         - Sector diversification (aim for 3-6 sectors, none > 35%)\n         - Industry diversification (none > 20%)\n         - Sentiment alignment (prefer bullish/neutral over bearish)\n         - Theme exposure (balance themed and non-themed stocks)\n\n      2. Assign weights:\n         - Higher scores can get higher weights (up to 10%)\n         - Lower scores should get lower weights (minimum 2%)\n         - Ensure weights sum to exactly 1.0 (100%)\n\n      3. Validate:\n         - Exactly 20 holdings\n         - Each weight between 0.02 and 0.1\n         - Total weight = 1.0\n         - No sector exceeds 35%\n         - No industry exceeds 20%\n\n      Output JSON strictly as:\n      {\n        \"holdings\": [\n          {\n            \"ticker\": \"AAPL\",\n            \"weight\": 0.08,\n            \"sector\": \"Information Technology\",\n            \"theme\": null,\n            \"rationale\": \"High composite score (0.75), strong sentiment, sector leader\",\n            \"composite_score\": 0.75\n          },\n          ... exactly 20 holdings ...\n        ]\n      }",
  "llm_response": {
    "holdings": [
      {
        "ticker": "NEM",
        "weight": 0.1,
        "sector": "Materials",
        "theme": null,
        "rationale": "Highest composite score (0.773), strong performance in gold market.",
        "composite_score": 0.773
      },
      {
        "ticker": "ADBE",
        "weight": 0.09,
        "sector": "Information Technology",
        "theme": "Digital Transformation Across Industries",
        "rationale": "Strong growth potential with AI integration, high score (0.660).",
        "composite_score": 0.66
      },
      {
        "ticker": "MRK",
        "weight": 0.08,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Promising pipeline and undervalued stock, score (0.642).",
        "composite_score": 0.642
      },
      {
        "ticker": "GOOGL",
        "weight": 0.08,
        "sector": "Communication Services",
        "theme": "AI Infrastructure Buildout",
        "rationale": "Strong position in AI, score (0.619).",
        "composite_score": 0.619
      },
      {
        "ticker": "V",
        "weight": 0.07,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Strong investor confidence and growth in fintech, score (0.602).",
        "composite_score": 0.602
      },
      {
        "ticker": "MA",
        "weight": 0.07,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Expanding digital payment capabilities, score (0.566).",
        "composite_score": 0.566
      },
      {
        "ticker": "SHOP",
        "weight": 0.06,
        "sector": "Consumer Discretionary",
        "theme": "E-Commerce and Consumer Behavior Evolution",
        "rationale": "Significant growth potential, score (0.520).",
        "composite_score": 0.52
      },
      {
        "ticker": "META",
        "weight": 0.06,
        "sector": "Communication Services",
        "theme": null,
        "rationale": "Investments in AI and energy markets, score (0.510).",
        "composite_score": 0.51
      },
      {
        "ticker": "JPM",
        "weight": 0.05,
        "sector": "Financials",
        "theme": "Interest Rate Sensitivity and Financial Sector Dynamics",
        "rationale": "Positive outlook for big banks, score (0.507).",
        "composite_score": 0.507
      },
      {
        "ticker": "REGN",
        "weight": 0.05,
        "sector": "Health Care",
        "theme": "Healthcare Innovation and Value Investing",
        "rationale": "Promising oncology pipeline, score (0.500).",
        "composite_score": 0.5
      },
      {
        "ticker": "AAPL",
        "weight": 0.05,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Strong growth potential with new product launches, score (0.478).",
        "composite_score": 0.478
      },
      {
        "ticker": "ABT",
        "weight": 0.04,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Expansion in glucose monitoring, score (0.446).",
        "composite_score": 0.446
      },
      {
        "ticker": "VZ",
        "weight": 0.04,
        "sector": "Communication Services",
        "theme": null,
        "rationale": "Strategic partnerships for network enhancement, score (0.443).",
        "composite_score": 0.443
      },
      {
        "ticker": "JNJ",
        "weight": 0.03,
        "sector": "Health Care",
        "theme": null,
        "rationale": "New product approvals enhancing growth prospects, score (0.441).",
        "composite_score": 0.441
      },
      {
        "ticker": "SYK",
        "weight": 0.03,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Strong dividend growth and AI advancements, score (0.440).",
        "composite_score": 0.44
      },
      {
        "ticker": "PFE",
        "weight": 0.02,
        "sector": "Health Care",
        "theme": null,
        "rationale": "Undervalued with potential in cancer treatments, score (0.425).",
        "composite_score": 0.425
      },
      {
        "ticker": "NVDA",
        "weight": 0.02,
        "sector": "Information Technology",
        "theme": "AI Infrastructure Buildout",
        "rationale": "Leading position in AI technology, score (0.417).",
        "composite_score": 0.417
      },
      {
        "ticker": "CSCO",
        "weight": 0.02,
        "sector": "Information Technology",
        "theme": null,
        "rationale": "Strong demand for AI technologies, score (0.416).",
        "composite_score": 0.416
      }
    ]
  },
  "model": "gpt-4o-mini",
  "timestamp": "2025-12-18T06:57:33.008622"
}